(Q55066872)

English

Renal and neurohormonal changes following simultaneous administration of systemic vasoconstrictors and dopamine or prostacyclin in cirrhotic patients with hepatorenal syndrome.

scientific article published in December 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/9007721

Renal and neurohormonal changes following simultaneous administration of systemic vasoconstrictors and dopamine or prostacyclin in cirrhotic patients with hepatorenal syndrome. (English)

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/9007721

liver cirrhosis

0 references

Wladimiro Jiménez

9

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/9007721

10

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/9007721

author name string

Saló J

1

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/9007721

Ginès A

2

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/9007721

Quer JC

3

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/9007721

Fernández-Esparrach G

4

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/9007721

Guevara M

5

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/9007721

Ginès P

6

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/9007721

Bataller R

7

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/9007721

Planas R

8

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/9007721

Rodés J

11

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/9007721

publication date

1 December 1996

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/9007721

Journal of Hepatology

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/9007721

25

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/9007721

6

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/9007721

916-923

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/9007721

Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980297-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Sympathetic nervous activity, renin-angiotensin system and renal excretion of prostaglandin E2in cirrhosis. Relationship to functional renal failure and sodium and water excretion

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980297-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980297-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Renal effects of natriuretic peptide receptor blockade in cirrhotic rats with ascites.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980297-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathogenesis and management of the hepatorenal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980297-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis. Effects on renal hemodynamics and atrial natriuretic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980297-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980297-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of the renin-angiotensin system in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980297-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Systemic and regional hemodynamics in patients with liver cirrhosis and ascites with and without functional renal failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980297-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Antidiuretic hormone and the pathogenesis of water retention in cirrhosis with ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980297-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Beneficial effect of 8-ornithin vasopressin on renal dysfunction in decompensated cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980297-2

7 January 2021

based on heuristic

inferred from DOI database lookup

EFFECT OF DOPAMINE IN MAN: AUGMENTATION OF SODIUM EXCRETION, GLOMERULAR FILTRATION RATE, AND RENAL PLASMA FLOW

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980297-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the effects of dopamine, dobutamine, and dopexamine upon renal blood flow: a study in normal healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980297-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Response to Dopamine Hydrochloride in the Hepatorenal Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980297-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Systemic, splanchnic and renal hemodynamic effects of a dopaminergic dose of dopamine in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980297-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Dopamine infusion in man. Plasma catecholamine levels and pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980297-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between infusion rates, plasma concentrations, and cardiovascular and metabolic effects during the infusion of norepinephrine in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980297-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Sodium excretion in advanced cirrhosis: effect of expansion of central blood volume and suppression of plasma aldosterone

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980297-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Interrelationship between cardiac output and vascular resistance as determinants of effective arterial blood volume in cirrhotic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980297-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Renal insensitivity to atrial natriuretic peptide in patients with cirrhosis and ascites. Effect of increasing systemic arterial pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980297-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Renal effects in cirrhotic patients with avid sodium retention of atrial natriuretic factor injection during norepinephrine infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980297-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Renal function in cirrhosis and the effects of prostaglandin A1

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980297-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Reversal of hepatorenal syndrome in four patients by peroral misoprostol (prostaglandin E1 analogue) and albumin administration

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980297-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of iloprost, a prostacyclin analog derivative, on renal plasma flow, renal function, and renin-aldosterone system in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980297-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostacyclin stimulates the renin angiotensin aldosterone system in man

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980297-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence for a direct stimulatory effect of prostacyclin on renin release in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980297-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral misoprostol or intravenous prostaglandin E2 do not improve renal function in patients with cirrhosis and ascites with hyponatremia or renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980297-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0168-8278(96)80297-2

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/9007721

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/9007721

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q55066872&oldid=1402254958"